Related references
Note: Only part of the references are listed.High mitochondrial content is associated with breast cancer aggressiveness
Patrick Lebok et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase
Marco Fiorillo et al.
CELL DEATH AND DIFFERENTIATION (2021)
Identification and functional validation of FDA-approved positive and negative modulators of the mitochondrial calcium uniporter
Agnese De Mario et al.
CELL REPORTS (2021)
MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo
Camillo Sargiacomo et al.
FRONTIERS IN ONCOLOGY (2021)
First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: Mitoriboscins and TPP compounds
Bela Ozsvari et al.
AGING-US (2020)
ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration
Nelli Mnatsakanyan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
Cristina Nuevo-Tapioles et al.
NATURE COMMUNICATIONS (2020)
Structure of the dimeric ATP synthase from bovine mitochondria
Tobias E. Spikes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity
Bela Ozsvari et al.
FRONTIERS IN ONCOLOGY (2020)
Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
Min Luo et al.
COMMUNICATIONS BIOLOGY (2020)
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
Frank Madeo et al.
CELL METABOLISM (2019)
Frailty index as a biomarker of lifespan and healthspan: Focus on pharmacological interventions
Dushani L. Palliyaguru et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2019)
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Yufeng Shi et al.
NATURE (2019)
Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function
Eligio F. Iannetti et al.
FRONTIERS IN GENETICS (2019)
Energetic Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
Marco Fiorillo et al.
FRONTIERS IN ONCOLOGY (2019)
Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)
Marco Fiorillo et al.
AGING-US (2019)
An update of the chemiosmotic theory as suggested by possible proton currents inside the coupling membrane
Alessandro Maria Morelli et al.
OPEN BIOLOGY (2019)
Purified F-ATP synthase forms a Ca2+-dependent high-conductance channel matching the mitochondrial permeability transition pore
Andrea Urbani et al.
NATURE COMMUNICATIONS (2019)
The enigmatic ATP supply of the endoplasmic reticulum
Maria R. Depaoli et al.
BIOLOGICAL REVIEWS (2019)
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography
Hannah E. Greenwood et al.
CLINICAL CANCER RESEARCH (2019)
The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance
Houman Kahroba et al.
LIFE SCIENCES (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
A mitochondrial megachannel resides in monomeric F1FO ATP synthase
Nelli Mnatsakanyan et al.
NATURE COMMUNICATIONS (2019)
The Bioenergetics of Exercise
P. Darrell Neufer
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Exercise Metabolism: Fuels for the Fire
Mark Hargreaves et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs)
Bela Ozsvari et al.
AGING-US (2018)
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
Ernestina M. de Francesco et al.
BIOCHEMICAL JOURNAL (2018)
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism
Marco Fiorillo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Assembly of the membrane domain of ATP synthase in human mitochondria
Jiuya He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX
Federica Sotgia et al.
CELL CYCLE (2018)
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy
Marco Fiorillo et al.
AGING-US (2018)
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
Cristian Scatena et al.
FRONTIERS IN ONCOLOGY (2018)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Oxidative phosphorylation: regulation and role in cellular and tissue metabolism
David F. Wilson
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
Federica Sotgia et al.
Oncotarget (2017)
Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)
Bela Ozsvari et al.
ONCOTARGET (2017)
Mitochondrial power drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
Marco Fiorillo et al.
ONCOTARGET (2017)
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)
Ernestina Marianna De Francesco et al.
ONCOTARGET (2017)
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
Lucia Garcia-Ledo et al.
FRONTIERS IN ONCOLOGY (2017)
Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy
Bela Ozsvari et al.
AGING-US (2017)
Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance
Elie Hatem et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Regulation of the H+-ATP synthase by IF1: a role in mitohormesis
Pau B. Esparza-Molto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
A Multisite-Binding Switchable Fluorescent Probe for Monitoring Mitochondrial ATP Level Fluctuation in Live Cells
Lu Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
Marco Fiorillo et al.
AGING-US (2016)
Imaging Adenosine Triphosphate (ATP)
Megha Rajendran et al.
BIOLOGICAL BULLETIN (2016)
Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice
W. P. Vermeij et al.
NATURE (2016)
Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
Aysegul Cort et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
Marco Fiorillo et al.
ONCOTARGET (2016)
Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?
Maria Peiris-Pages et al.
CELL METABOLISM (2015)
Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
Rebecca Lamb et al.
ONCOTARGET (2015)
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
Rebecca Lamb et al.
ONCOTARGET (2015)
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
Rebecca Lamb et al.
ONCOTARGET (2015)
High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
Gillian Farnie et al.
ONCOTARGET (2015)
Torque Generation Mechanism of F1-ATPase upon NTP Binding
Hidenobu C. Arai et al.
BIOPHYSICAL JOURNAL (2014)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
ATP Synthase: The Right Size Base Model for Nanomotors in Nanomedicine
Zulfiqar Ahmad et al.
SCIENTIFIC WORLD JOURNAL (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
The ATP synthase: the understood, the uncertain and the unknown
John E. Walker
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Caloric restriction augments radiation efficacy in breast cancer
Anthony D. Saleh et al.
CELL CYCLE (2013)
Contribution of intracellular ATP to cisplatin resistance of tumor cells
Verena Schneider et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Nutrient Restriction and Radiation Therapy for Cancer Treatment: When Less Is More
Colin E. Champ et al.
ONCOLOGIST (2013)
A Simple High-Content Cell Cycle Assay Reveals Frequent Discrepancies between Cell Number and ATP and MTS Proliferation Assays
Grace Ka Yan Chan et al.
PLOS ONE (2013)
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
M. Sanchez-Arago et al.
ONCOGENESIS (2013)
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
Yunfei Zhou et al.
CANCER RESEARCH (2012)
Mitochondrial metabolism in cancer metastasis Visualizing tumor cell mitochondria and the reverse Warburg effect in positive lymph node tissue
Federica Sotgia et al.
CELL CYCLE (2012)
Power Surge: Supporting Cells Fuel Cancer Cell Mitochondria
Ubaldo E. Martinez-Outschoorn et al.
CELL METABOLISM (2012)
Molecular Mechanism of ATP Hydrolysis in F1-ATPase Revealed by Molecular Simulations and Single-Molecule Observations
Shigehiko Hayashi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The Mitochondrial ATPase Inhibitory Factor 1 Triggers a ROS-Mediated Retrograde Prosurvival and Proliferative Response
Laura Formentini et al.
MOLECULAR CELL (2012)
ATP synthesis and storage
Massimo Bonora et al.
PURINERGIC SIGNALLING (2012)
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ Visualizing the therapeutic effects of metformin in tumor tissue
Diana Whitaker-Menezes et al.
CELL CYCLE (2011)
Paul D. Boyer—Nobel Prize for Work on ATP Synthase
Marc A. Shampo et al.
MAYO CLINIC PROCEEDINGS (2011)
Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?
Ilaria Chiodi et al.
Cancers (2011)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
THE DOUBLE LIFE OF ATP
Baljit S. Khakh et al.
SCIENTIFIC AMERICAN (2009)
Molecular correlates for maximal oxygen uptake and type 1 fibers
Hemang Parikh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Karl Lohmann and the discovery of ATP
Peter Langen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals
JB Zheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
